You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

List of Excipients in API EZETIMIBE


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing EZETIMIBE

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Rebel Distributors Corp ZETIA ezetimibe 21695-778 CELLULOSE, MICROCRYSTALLINE
Rebel Distributors Corp ZETIA ezetimibe 21695-778 CROSCARMELLOSE SODIUM
Rebel Distributors Corp ZETIA ezetimibe 21695-778 LACTOSE MONOHYDRATE
Rebel Distributors Corp ZETIA ezetimibe 21695-778 MAGNESIUM STEARATE
Rebel Distributors Corp ZETIA ezetimibe 21695-778 POVIDONE
Rebel Distributors Corp ZETIA ezetimibe 21695-778 SODIUM LAURYL SULFATE
Physicians Total Care Inc ZETIA ezetimibe 54868-4719 CELLULOSE, MICROCRYSTALLINE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Start Trial

Excipients in ANDA-approved (generic) drugs containing EZETIMIBE

Company Ingredient NDC Excipient
Actavis Pharma Inc ezetimibe 0591-3713 CELLULOSE, MICROCRYSTALLINE
Actavis Pharma Inc ezetimibe 0591-3713 CROSCARMELLOSE SODIUM
Actavis Pharma Inc ezetimibe 0591-3713 CROSPOVIDONE
Actavis Pharma Inc ezetimibe 0591-3713 HYPROMELLOSE 2910
Actavis Pharma Inc ezetimibe 0591-3713 LACTOSE MONOHYDRATE
Actavis Pharma Inc ezetimibe 0591-3713 MAGNESIUM STEARATE
Actavis Pharma Inc ezetimibe 0591-3713 SODIUM LAURYL SULFATE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Start Trial

Detailed excipient profiles for EZETIMIBE

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: ASCORBIC ACID

Excipient focus: BUTYLATED HYDROXYANISOLE

EZETIMIBE drug variants containing BUTYLATED HYDROXYANISOLE

Company Ingredient NDC
NORTHSTAR RX LLC ezetimibe and simvastatin 16714-778
Rebel Distributors Corp ezetimibe and simvastatin 21695-325
AvKARE ezetimibe and simvastatin 42291-078
DrReddys Laboratories Inc ezetimibe and simvastatin 43598-742
Actavis Pharma Inc ezetimibe and simvastatin 45963-565
Actavis Pharma Inc ezetimibe and simvastatin 45963-566
A-S Medication Solutions ezetimibe and simvastatin 50090-3984
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CITRIC ACID MONOHYDRATE

EZETIMIBE drug variants containing CITRIC ACID MONOHYDRATE

Company Ingredient NDC
NORTHSTAR RX LLC ezetimibe and simvastatin 16714-778
Rebel Distributors Corp ezetimibe and simvastatin 21695-325
AvKARE ezetimibe and simvastatin 42291-078
DrReddys Laboratories Inc ezetimibe and simvastatin 43598-742
A-S Medication Solutions ezetimibe and simvastatin 50090-3984
A-S Medication Solutions ezetimibe and simvastatin 50090-4772
A-S Medication Solutions ezetimibe and simvastatin 50090-7047
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: CROSCARMELLOSE SODIUM

EZETIMIBE drug variants not containing CROSCARMELLOSE SODIUM

Company Ingredient NDC
A-S Medication Solutions ezetimibe 50090-7338
A-S Medication Solutions ezetimibe 50090-7339
ScieGen Pharmaceuticals Inc ezetimibe 50228-379
Zydus Pharmaceuticals USA Inc ezetimibe 68382-773
Glenmark Pharmaceuticals Inc USA ezetimibe 68462-226
Zydus Lifesciences Limited ezetimibe 70771-1109
Quallent Pharmaceuticals Health LLC ezetimibe 82009-024
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: CROSPOVIDONE

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: HYDROXYPROPYL METHYLCELLULOSE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2208

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

EZETIMIBE drug variants containing HYPROMELLOSES

Company Ingredient NDC
REMEDYREPACK INC ezetimibe 70518-2262
direct rx ezetimibe 72189-118
Rebel Distributors Corp ezetimibe and simvastatin 21695-325
AvKARE ezetimibe and simvastatin 42291-078
Physicians Total Care Inc ezetimibe and simvastatin 54868-5250
Amneal Pharmaceuticals NY LLC ezetimibe and simvastatin 60219-1155
Amneal Pharmaceuticals NY LLC ezetimibe and simvastatin 69238-1155
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MANNITOL

Excipient focus: MICROCRYSTALLINE CELLULOSE 101

Excipient focus: POLYSORBATE 80

Excipient focus: POVIDONE

Excipient focus: POVIDONE K30

Excipient focus: PROPYL GALLATE

EZETIMIBE drug variants containing PROPYL GALLATE

Company Ingredient NDC
NORTHSTAR RX LLC ezetimibe and simvastatin 16714-778
Rebel Distributors Corp ezetimibe and simvastatin 21695-325
AvKARE ezetimibe and simvastatin 42291-078
DrReddys Laboratories Inc ezetimibe and simvastatin 43598-742
Actavis Pharma Inc ezetimibe and simvastatin 45963-565
Actavis Pharma Inc ezetimibe and simvastatin 45963-566
A-S Medication Solutions ezetimibe and simvastatin 50090-3984
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: SILICA

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM LAURETH-12 SULFATE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: SODIUM STEARYL FUMARATE

Excipient focus: STARCH, CORN

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links